Wall Street Analysts Are Bearish on This Artificial Intelligence (AI) Stock. Here's Why I'm Not.

In This Article:

Buy-side stock analysts can be helpful. They often come with advanced financial skills and training, vetted through many years or even decades of experience in money management. So, it can make sense to check out what Wall Street professionals are saying about your next investing idea.

That said, they don't always have the right answers or the best analysis. In most cases, analysts' consensus stock ratings are backward-looking reviews of recent events -- not insightful projections of what could happen in the future.

The Street was only mildly enthusiastic about Nvidia before the ChatGPT release made it a market darling. When Netflix (NASDAQ: NFLX) was a no-brainer buy in the wake of the Qwikster crisis of 2011, the consensus analyst view on that stock was a hold, with a slight leaning to the bearish side. That turned out to be a fantastic time to buy Netflix stock, with returns of more than 5,300% in the next 12 years.

So, the analysts don't always get it right, not even when their average recommendation is unusually bearish. On that note, Wall Street's attitude toward computer-managed insurance company Lemonade (NYSE: LMND) reminds me of the old Netflix miscalculations right now. The consensus recommendation is a hold, with slightly more sell than buy outliers.

I think this recommendation will go down as one of the classic blunders. Here's why Lemonade's stock looks ready to soar from this low spot.

The market's consensus on Lemonade

Lemonade's current analyst rating is a slightly bearish hold. Among 10 analyst firms offering a rating on the stock, six are sticking with the middle-of-the-road hold advice. One stands out with a buy rating, while three suggest some sort of sell action.

Judging by their questions on Lemonade's latest earnings call, the bearish analysts worry about the company's exposure to catastrophic damage claims, or CAT. A plethora of damaging winter storms led to an unfavorable gross loss ratio, weighing on Lemonade's bottom-line profitability.

It's harder to determine the motivation for the lone bullish rating from Karol Chmiel of Citizens JMP group. The analyst rarely asks questions on the company's earnings calls, and JMP isn't keen on publishing its research reports publicly.

The bullish case for Lemonade

So, here's my own Lemonade analysis instead. I'm a longtime shareholder of this innovative insurance company, which started relying on artificial intelligence (AI) to manage its core business long before it was cool.

Lemonade's automated approach instantly makes sense to me from the consumer's point of view. Traditional insurance experts, like Progressive or Allstate, depend on human agents to recruit, sign up, assess, and manage customers. The process is prone to human error at every stage, and taking the emotion out of this business with computerized automation makes a ton of sense.